1. Home
  2. ANNX vs ALCO Comparison

ANNX vs ALCO Comparison

Compare ANNX & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANNX
  • ALCO
  • Stock Information
  • Founded
  • ANNX 2011
  • ALCO 1960
  • Country
  • ANNX United States
  • ALCO United States
  • Employees
  • ANNX N/A
  • ALCO N/A
  • Industry
  • ANNX Biotechnology: Pharmaceutical Preparations
  • ALCO
  • Sector
  • ANNX Health Care
  • ALCO
  • Exchange
  • ANNX Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • ANNX 253.8M
  • ALCO 257.5M
  • IPO Year
  • ANNX 2020
  • ALCO N/A
  • Fundamental
  • Price
  • ANNX $3.09
  • ALCO $33.84
  • Analyst Decision
  • ANNX Strong Buy
  • ALCO
  • Analyst Count
  • ANNX 4
  • ALCO 0
  • Target Price
  • ANNX $13.00
  • ALCO N/A
  • AVG Volume (30 Days)
  • ANNX 2.4M
  • ALCO 21.0K
  • Earning Date
  • ANNX 11-13-2025
  • ALCO 08-12-2025
  • Dividend Yield
  • ANNX N/A
  • ALCO 0.59%
  • EPS Growth
  • ANNX N/A
  • ALCO N/A
  • EPS
  • ANNX N/A
  • ALCO N/A
  • Revenue
  • ANNX N/A
  • ALCO $44,199,000.00
  • Revenue This Year
  • ANNX N/A
  • ALCO N/A
  • Revenue Next Year
  • ANNX N/A
  • ALCO N/A
  • P/E Ratio
  • ANNX N/A
  • ALCO N/A
  • Revenue Growth
  • ANNX N/A
  • ALCO N/A
  • 52 Week Low
  • ANNX $1.29
  • ALCO $24.23
  • 52 Week High
  • ANNX $7.85
  • ALCO $35.01
  • Technical
  • Relative Strength Index (RSI)
  • ANNX 60.42
  • ALCO 51.31
  • Support Level
  • ANNX $2.91
  • ALCO $33.42
  • Resistance Level
  • ANNX $3.38
  • ALCO $34.67
  • Average True Range (ATR)
  • ANNX 0.24
  • ALCO 0.57
  • MACD
  • ANNX 0.02
  • ALCO -0.04
  • Stochastic Oscillator
  • ANNX 61.87
  • ALCO 39.80

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: